Skip to Main Content

Author Details

Sebastian Schneeweiss
Division of Pharmacoepidemiology, Brigham & Women's Hospital, Harvard Medical School
1996
535
98
PMIDPaper TitleJournal TitlePublished Year
37604229Joint pain in patients with atopic dermatitis receiving treatment with dupilumab: A US nationwide cohort study.J Am Acad Dermatol2024
36345809Effectiveness research in oncology with electronic health record data: A retrospective cohort study emulating the PALOMA-2 trial.Pharmacoepidemiol Drug Saf2023
37755828Reporting of Observational Studies Explicitly Aiming to Emulate Randomized Trials: A Systematic Review.JAMA Netw Open2023
37699620Development of the TrAnsparent ReportinG of observational studies Emulating a Target trial (TARGET) guideline.BMJ Open2023
37744690Concepts of Designing and Implementing Pharmacoepidemiology Studies on the Safety of Systemic Treatments in Dermatology Practice.JID Innov2023
37502999DESIGN DIFFERENCES EXPLAIN VARIATION IN RESULTS BETWEEN RANDOMIZED TRIALS AND THEIR NON-RANDOMIZED EMULATIONS.medRxiv2023
37606676Understanding the Facets of Emulating Randomized Clinical Trials-Reply.JAMA2023
37677118Comparative Cardiovascular Effectiveness and Safety of SGLT-2 Inhibitors, GLP-1 Receptor Agonists, and DPP-4 Inhibitors According to Frailty in Type 2 Diabetes.Diabetes Care2023
37259575Sodium-glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study.Eur Heart J2023
37365904Predicting Treatment Effects of a New-to-Market Drug in Clinical Practice Based on Phase III Randomized Trial Results.Clin Pharmacol Ther2023
37097356Emulation of Randomized Clinical Trials With Nonrandomized Database Analyses: Results of 32 Clinical Trials.JAMA2023
37428347Real-World Tumor Response of Palbociclib in Combination With an Aromatase Inhibitor as First-Line Therapy in Pre/Perimenopausal Women With Metastatic Breast Cancer.Target Oncol2023
36753234Risk of Infection in Children With Psoriasis Receiving Treatment With Ustekinumab, Etanercept, or Methotrexate Before and After Labeling Expansion.JAMA Dermatol2023
36625307Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation.J Am Heart Assoc2023
36408668The Aetion Coalition to Advance Real-World Evidence through Randomized Controlled Trial Emulation Initiative: Oncology.Clin Pharmacol Ther2023
36403606Longitudinal utilization of systemic immunomodulators before and after dupilumab approval in children with atopic dermatitis.Pediatr Dermatol2023
36577843Hydroxychloroquine lowers Alzheimer's disease and related dementias risk and rescues molecular phenotypes related to Alzheimer's disease.Mol Psychiatry2023
36905959Use of systemic immunomodulating medications in pregnant women with atopic dermatitis: A nationwide US study.J Am Acad Dermatol2023
36528788Scalable Feature Engineering from Electronic Free Text Notes to Supplement Confounding Adjustment of Claims-Based Pharmacoepidemiologic Studies.Clin Pharmacol Ther2023
36941978Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets.Clin Epidemiol2023
36527843The influence of the COVID-19 pandemic on the prescription of multiple sclerosis medication in Germany.Biomed Pharmacother2023
36527432Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis.Pharmacoepidemiol Drug Saf2023
36938914Antidiabetes medication initiation trends in US adults with cirrhosis and type 2 diabetes: A nationwide study.Diabetes Obes Metab2023
36657590Strong instrumental variables biased propensity scores in comparative effectiveness research: A case study in oncology.J Clin Epidemiol2023
36215113HARmonized Protocol Template to Enhance Reproducibility of hypothesis evaluating real-world evidence studies on treatment effects: A good practices report of a joint ISPE/ISPOR task force.Pharmacoepidemiol Drug Saf2023
33387667Risk of Serious Infections With Vedolizumab Versus Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease.Clin Gastroenterol Hepatol2022
35439779Synthetic Negative Controls: Using Simulation to Screen Large-scale Propensity Score Analyses.Epidemiology2022
35605236Cardiovascular Outcomes in Patients Initiating First-Line Treatment of Type 2 Diabetes With Sodium-Glucose Cotransporter-2 Inhibitors Versus Metformin : A Cohort Study.Ann Intern Med2022
35394510Comparative Risk of Alzheimer Disease and Related Dementia Among Medicare Beneficiaries With Rheumatoid Arthritis Treated With Targeted Disease-Modifying Antirheumatic Agents.JAMA Netw Open2022
35718888Occurrence of inflammatory bowel disease in patients with chronic inflammatory skin diseases: a cohort study: Classification: Epidemiology.Br J Dermatol2022
35689603Sacubitril/valsartan use patterns among older adults with heart failure in clinical practice: a population-based cohort study of >25â¿¿000 Medicare beneficiaries.Eur J Heart Fail2022
35520277A Framework for Visualizing Study Designs and Data Observability in Electronic Health Record Data.Clin Epidemiol2022
35387877Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn's disease.Gut2022
35357470Impact of longitudinal data-completeness of electronic health record data on risk score misclassification.J Am Med Inform Assoc2022
36540900Statin Use and Severe Acute Liver Injury Among Patients with Elevated Alanine Aminotransferase.Clin Epidemiol2022
36150454Comparative effectiveness of Empagliflozin in reducing the burden of recurrent cardiovascular hospitalizations among older adults with diabetes in routine clinical care.Am Heart J2022
36075314Understanding variation in the results of real-world evidence studies that seem to address the same question.J Clin Epidemiol2022
36246306Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation.Clin Epidemiol2022
36146536Durability of Protection Post-Primary COVID-19 Vaccination in the United States.Vaccines (Basel)2022
36241338HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force.Value Health2022
36330433No association between initiation of phosphodiesterase-5 inhibitors and risk of incident Alzheimer's disease and related dementia: results from the Drug Repurposing for Effective Alzheimer's Medicines study.Brain Commun2022
36170656Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study.Diabetes Care2022
36264574Comparative Effectiveness of Empagliflozin vs Liraglutide or Sitagliptin in Older Adults With Diverse Patient Characteristics.JAMA Netw Open2022
36167266Obesity as a modifier of the cardiovascular effectiveness of sodium-glucose cotransporter-2 inhibitors in type 2 diabetes.Diabetes Res Clin Pract2022
35984046Visualizations throughout pharmacoepidemiology study planning, implementation, and reporting.Pharmacoepidemiol Drug Saf2022
36387928Advancing an Algorithm for the Identification of Patients with High Data-Continuity in Electronic Health Records.Clin Epidemiol2022
35947646Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety.JNCI Cancer Spectr2022
35878784An algorithm to predict data completeness in oncology electronic medical records for comparative effectiveness research.Ann Epidemiol2022
34985178Evolving channeling in prescribing SGLT-2 inhibitors as first-line treatment for type 2 diabetes.Pharmacoepidemiol Drug Saf2022
35092316Transparency of high-dimensional propensity score analyses: Guidance for diagnostics and reporting.Pharmacoepidemiol Drug Saf2022
  • 1 - 50 of 535

Recommended Authors

Erica A Voss
Erasmus University Medical Center
Career Start Year 2014
Number of shared co-authors 5
Hemalkumar B Mehta
Johns Hopkins Bloomberg School of Public Health
Career Start Year 2012
Number of shared co-authors 4
Azza Shoaibi
Janssen Pharmaceutical Research and Development
Career Start Year 2010
Number of shared co-authors 8
Raluca Ionescu-Ittu
Analysis Group Inc.
Career Start Year 2007
Number of shared co-authors 1
Craig W Newcomb
University of Pennsylvania Perelman School of Medicine
Career Start Year 2007
Number of shared co-authors 0
Robert A Greevy
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 1
Christianne L Roumie
Vanderbilt University Medical Center
Career Start Year 2004
Number of shared co-authors 4
Christine Y Lu
Harvard Medical School and the Harvard Pilgrim Health Care Institute
Career Start Year 2004
Number of shared co-authors 4
Jalpa A Doshi
University of Pennsylvania Perelman School of Medicine
Career Start Year 2002
Number of shared co-authors 1
Qingxia Chen
Vanderbilt University Medical Center
Career Start Year 2002
Number of shared co-authors 3
Michele Jonsson Funk
University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 4
Nilay D Shah
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 2
Martijn J Schuemie
University of California los angeles
Career Start Year 2001
Number of shared co-authors 15
Joseph S Ross
Yale School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Matthew L Maciejewski
Duke University
Career Start Year 1997
Number of shared co-authors 3
Alistair J O'Malley
The Dartmouth Institute, Geisel School of Medicine at Dartmouth
Career Start Year 1997
Number of shared co-authors 3
Emily Beth Devine
University of Washington
Career Start Year 1997
Number of shared co-authors 5
Manisha Desai
Stanford University
Career Start Year 1997
Number of shared co-authors 4
George Caleb Alexander
Institute of General Practice and Family Medicine, University Hospital
Career Start Year 1996
Number of shared co-authors 3
Stephen E Kimmel
University of Florida
Career Start Year 1995
Number of shared co-authors 4
Rachel Weinstein
Rush University Medical Center
Career Start Year 1995
Number of shared co-authors 2
Todd A MacKenzie
Geisel School of Medicine at Dartmouth
Career Start Year 1992
Number of shared co-authors 2
Jason N Doctor
University of Southern California
Career Start Year 1992
Number of shared co-authors 1
Sharon-Lise T Normand
Harvard Medical School
Career Start Year 1988
Number of shared co-authors 9
Jerry H Gurwitz
university of massachusetts amherst Chan Medical School
Career Start Year 1988
Number of shared co-authors 11
Robert S Epstein
Epstein Health LLC
Career Start Year 1988
Number of shared co-authors 2
Anna Localio
University of Pennsylvania Perelman School of Medicine
Career Start Year 1985
Number of shared co-authors 4
Endel J Orav
Brigham and Women's Hospital
Career Start Year 1982
Number of shared co-authors 9
Dennis W Raisch
The University of New Mexico
Career Start Year 1977
Number of shared co-authors 0
Brian L Strom
Center for Pharmacoepidemiology and Treatment Science, Rutgers University
Career Start Year 1970
Number of shared co-authors 9

Collaborators

Joshua J Gagne
Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
Co-authored papers 73
Jeremy A Rassen
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 61
Elisabetta Patorno
Harvard Medical School
Co-authored papers 57
Shirley V Wang
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 47
Rishi J Desai
Harvard Medical School
Co-authored papers 34
Soko Setoguchi
Rutgers University Institute for Health, the State University of New Jersey
Co-authored papers 24
Alexander M Walker
Harvard T.H. Chan School of Public Health
Co-authored papers 18
Til St??rmer
University of North Carolina at Chapel Hill
Co-authored papers 16
Jeffrey N Katz
Orthopedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital
Co-authored papers 13
Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 10
Michael Fralick
University of Toronto
Co-authored papers 10
Michael E Weinblatt
Co-authored papers 9
Jeffrey S Brown
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 8
Aaron S Kesselheim
Brigham and Women's Hospital.
Co-authored papers 8
Shawn N Murphy
Harvard Medical School
Co-authored papers 7
James R Rogers
Columbia University
Co-authored papers 6
Gerald J Dal Pan
Center for Drug Evaluation and Research
Co-authored papers 6
Jennifer C Nelson
Kaiser Permanente Washington Health Research Institute
Co-authored papers 6
Olaf H Klungel
Co-authored papers 6
Daniel E Singer
Clinical Epidemiology Unit, Massachusetts General Hospital
Co-authored papers 5
Michael Nguyen
Center for Drug Evaluation and Research
Co-authored papers 5
Nicole L Pratt
Quality Use of Medicines and Pharmacy Research Centre, University of South Australia
Co-authored papers 3
Deborah Schrag
Memorial-Sloan Kettering Cancer Center
Co-authored papers 3
Miriam C J M Sturkenboom
University Medical Center Utrecht
Co-authored papers 3
Kenneth D Mandl
Boston Children's Hospital
Co-authored papers 3
Eric G Campbell
Center for Bioethics and Humanities, University of Colorado School of Medicine
Co-authored papers 3
Bruce C Carleton
BC Children's Hospital Research Institute
Co-authored papers 3
Elliott M Antman
Co-authored papers 3
Judith C Maro
Harvard Pilgrim Health Care Institute and Harvard Medical School
Co-authored papers 3
Richard Platt
Harvard Medical School and Harvard Pilgrim Health Care Institute
Co-authored papers 2
Release 1.2